BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26227220)

  • 1. Let-7a-3 hypomethylation is associated with favorable/intermediate karyotypes but not with survival in acute myeloid leukemia.
    Zhu XW; Yao DM; Wu DH; Wen XM; Yang J; Guo H; Yang L; Deng ZQ; Zhang YY; Qian W; Lin J; Qian J
    Tumour Biol; 2016 Jan; 37(1):491-501. PubMed ID: 26227220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA let-7a-3 gene methylation is associated with karyotyping, CEBPA promoter methylation, and survival in acute myeloid leukemia.
    Ko YC; Fang WH; Lin TC; Hou HA; Chen CY; Tien HF; Lin LI
    Leuk Res; 2014 May; 38(5):625-31. PubMed ID: 24703161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressed let-7a-3 is associated with poor outcome in acute myeloid leukemia.
    Li Y; Lin J; Yang J; Qian J; Qian W; Yao DM; Deng ZQ; Liu Q; Chen XX; Xie D; An C; Tang CY
    Leuk Res; 2013 Dec; 37(12):1642-7. PubMed ID: 24138945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5' flanking region of miR-378 is hypomethylated in acute myeloid leukemia.
    Zhu XW; Wen XM; Zhang YY; Yang L; Guo H; Yang J; Zhang M; Yin JY; Ma JC; Lin J; Deng ZQ; Qian J
    Int J Clin Exp Pathol; 2015; 8(5):4321-31. PubMed ID: 26191124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DDX43 promoter is frequently hypomethylated and may predict a favorable outcome in acute myeloid leukemia.
    Lin J; Chen Q; Yang J; Qian J; Deng ZQ; Qian W; Chen XX; Ma JC; Xiong DS; Ma YJ; An C; Tang CY
    Leuk Res; 2014 May; 38(5):601-7. PubMed ID: 24656837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia.
    Jinlong S; Lin F; Yonghui L; Li Y; Weidong W
    PLoS One; 2015; 10(2):e0118099. PubMed ID: 25646775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics.
    Seyyedi SS; Soleimani M; Yaghmaie M; Ajami M; Ajami M; Pourbeyranvand S; Alimoghaddam K; Akrami SM
    Tumour Biol; 2016 Apr; 37(4):4841-7. PubMed ID: 26526573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
    Sun GK; Tang LJ; Zhou JD; Xu ZJ; Yang L; Yuan Q; Ma JC; Liu XH; Lin J; Qian J; Yao DM
    Cancer Med; 2019 Oct; 8(14):6393-6402. PubMed ID: 31486300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant hypomethylation of SALL4 gene is associated with intermediate and poor karyotypes in acute myeloid leukemia.
    Ma JC; Qian J; Lin J; Qian W; Yang J; Wang CZ; Chai HY; Li Y; Chen Q; Qian Z
    Clin Biochem; 2013 Mar; 46(4-5):304-7. PubMed ID: 23201546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MOK overexpression is associated with promoter hypomethylation in patients with acute myeloid leukemia.
    Qian J; Chen Q; Yao DM; Yang L; Yang J; Wen XM; Zhang YY; Chai HY; Ma JC; Deng ZQ; Lin J
    Int J Clin Exp Pathol; 2015; 8(1):127-36. PubMed ID: 25755699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low SOX17 expression: prognostic significance in de novo acute myeloid leukemia with normal cytogenetics.
    Tang CY; Lin J; Qian W; Yang J; Ma JC; Deng ZQ; Yang L; An C; Wen XM; Zhang YY; Qian J
    Clin Chem Lab Med; 2014 Dec; 52(12):1843-50. PubMed ID: 24955525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
    Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypomethylation of let-7a-3 is associated with poor prognosis in myelodysplastic syndrome.
    Wu DH; Yao DM; Yang L; Ma JC; Wen XM; Yang J; Guo H; Li XX; Qian W; Lin J; Qian J
    Leuk Lymphoma; 2017 Jan; 58(1):96-103. PubMed ID: 27244225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased SCIN expression, associated with promoter methylation, is a valuable predictor for prognosis in acute myeloid leukemia.
    Zhang ZH; Zhang W; Zhou JD; Zhang TJ; Ma JC; Xu ZJ; Lian XY; Wu DH; Wen XM; Deng ZQ; Lin J; Qian J
    Mol Carcinog; 2018 Jun; 57(6):735-744. PubMed ID: 29457658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of microRNA-34b expression in pediatric acute leukemia.
    Cao L; Wang N; Pan J; Hu S; Zhao W; He H; Wang Y; Gu G; Chai Y
    Mol Med Rep; 2016 Mar; 13(3):2777-84. PubMed ID: 26861642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNMT3A intragenic hypomethylation is associated with adverse prognosis in acute myeloid leukemia.
    Zhang YY; Yao DM; Zhu XW; Zhou JD; Ma JC; Yang J; Wen XM; Guo H; Lin J; Qian J
    Leuk Res; 2015 Oct; 39(10):1041-7. PubMed ID: 26242829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased SFRP2 expression is associated with intermediate and poor karyotypes in de novo acute myeloid leukemia.
    Guo H; Lin J; Wen XM; Yang J; Qian W; Deng ZQ; Ma JC; Tang CY; An C; Liu Q; Zhou H; Qian J
    Int J Clin Exp Pathol; 2014; 7(8):4695-703. PubMed ID: 25197341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients.
    Tao YF; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Xu LX; Li ZH; Wang NN; Du XJ; Sun LC; Zhao H; Fang F; Su GH; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    Int J Mol Med; 2014 Dec; 34(6):1505-15. PubMed ID: 25319049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.
    Zhou JD; Zhang TJ; Wang YX; Yang DQ; Yang L; Ma JC; Wen XM; Yang J; Lin J; Qian J
    Tumour Biol; 2016 Jul; 37(7):8951-60. PubMed ID: 26753961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.